News

DNAtrix, a clinical stage biotechnology company developing virus-driven immunotherapies for cancer, announced the award of a $2 million research grant from the FDA’s Office of Orphan…
Read More...

Medidata announced that its cloud technology platform has been adopted by Pluristem Therapeutics. The Israeli biotech will deploy Medidata Rave to capture, manage and maximize the value…
Read More...

Allergan has completed the divestiture of its global generic pharmaceuticals business to Teva Pharmaceutical Industries. Allergan has received $33.4 billion in cash and 100.3 million…
Read More...

Ligand Pharmaceuticals Incorporated announces the signing of a license agreement for three programs utilizing Ligand’s LTP (Liver Targeting Prodrug) technology with Nucorion…
Read More...

DNAtrix, a clinical stage biotechnology company developing virus-driven immunotherapies for cancer, announced that the European Medicines Agency (EMA) has granted PRIority MEdicines…
Read More...

Synaffix has completed a new set of preclinical studies that further supports the potential for its technology to enable safer and more effective targeted cancer therapeutics. The…
Read More...

DNAtrix, a clinical stage, biotechnology company developing virus-driven immunotherapies for cancer, announced the successful intratumoral administration of DNX-2401 with the Alcyone…
Read More...

PeptiDream has entered into a Technology License Agreement with US-based Genentech, a member of the Roche Group, to non exclusively license its Peptide Discovery Platform System (PDPS)…
Read More...

Medidata announced that it has signed a multi-year enterprise deal with Hanmi Pharmaceutical, one of South Korea's leading drug makers. A Medidata customer since 2013, the …
Read More...

Oracle announced that after a detailed review and selection process, Pfizer has selected Oracle Health Sciences InForm Cloud Service and the Oracle Siebel Clinical Trial Management and…
Read More...

An innovative virtual reality smartphone app – A Walk Through Dementia – will launch at a three-day public installation at St Pancras International Station from 2 June. The…
Read More...

Delivra has entered into a technology licensing agreement with Kalytera Therapeutics. Based in California, Kalytera is a pharmaceutical company developing a portfolio of…
Read More...

Integral Molecular has developed an ultra high-throughput microfluidic B-cell cloning technology that can interrogate tens of millions of immune cells (B-cells), enabling deep mining of…
Read More...

PaizaBio has secured an agreement with Taiwan-based JHL Biotech to provide fill-finish services for multiple JHL projects. New Mexico-based PaizaBio will provide these services to…
Read More...

Bayer and ERS signed a patent license agreement whereby Bayer gains access to ERS’ CRISPR-Cas9 genome-editing patents for certain cross-divisional applications in Bayer’s core strategic…
Read More...

As one of medicine’s largest challenges, viral infections often escape vaccines due to their natural ability to mutate rapidly and develop drug resistance easily. Many viruses, such as…
Read More...

In an advance that could lead to the development of better treatments for viral pathogens, such as Zika, a team of scientists at the California NanoSystems Institute at UCLA are…
Read More...

International Biotechnology Center "Generium", (LLC IBC Generium), a private scientific research company in Russia that is committed to developing and delivering innovative, effective,…
Read More...

biOasis Technologies has entered into a License Agreement to collaborate with Astellas Research Institute of America (Astellas). The terms of the agreement, for competitive reasons,…
Read More...

Bristol-Myers Squibb has selected the Medidata Clinical Cloud to help manage, monitor and analyze its clinical trials. Medidata's cutting-edge technology platform will support…
Read More...